Sciwind begins clinical trial of XW014 for Obesity and T2DM
Sciwind Biosciences has initiated of dosing in a Phase 1 clinical trial evaluating XW014, a novel oral small molecule glucagon-like...
top of page
Browse by category
Search
Browse by tag
bottom of page